Experienced in WT1-Related Wilms Tumor Syndromes

Dr. Christopher R. Mason

Hematology Oncology | Hematology | Oncology
Albany Medical Center Health System
Glens Falls Hospital Inc
100 Park St, Glens Falls Hospital Credentialing, 
Glens Falls, NY 
Clinical Trials:Currently Recruiting for 2 Trials
17 Years of Experience

Experienced in WT1-Related Wilms Tumor Syndromes
Albany Medical Center Health System
Glens Falls Hospital Inc
100 Park St, Glens Falls Hospital Credentialing, 
Glens Falls, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Christopher Mason is a Hematologist Oncology specialist and a Hematologist in Glens Falls, New York. Dr. Mason has been practicing medicine for over 17 years and is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Familial Pancreatic Cancer, Paget Disease of the Breast, and Bone Marrow Aspiration.

His clinical research consists of co-authoring 1 peer reviewed article and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Year
2009
Specialties
Hematology Oncology
Hematology
Oncology
Licenses
Internal Medicine in NY
Hospital Affiliations
Saratoga Hospital
Glens Falls Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital District Physicians Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MVP Health
  • EPO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

GLENS FALLS HOSPITAL INC
100 Park St, Glens Falls Hospital Credentialing, Glens Falls, NY 12801
Call: 518-642-0612
Other Locations
GLENS FALLS HOSPITAL INC
79 N St, Granville Medical Center, Granville, NY 12832
Call: 518-642-0612

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


5 Clinical Trials

Effective Quadruplet Utilization After Treatment Evaluation (EQUATE): A Randomized Phase 3 Trial for Newly Diagnosed Multiple Myeloma Not Intended for Early Autologous Transplantation
Effective Quadruplet Utilization After Treatment Evaluation (EQUATE): A Randomized Phase 3 Trial for Newly Diagnosed Multiple Myeloma Not Intended for Early Autologous Transplantation
Enrollment Status: Recruiting
Publish Date: November 13, 2025
Intervention Type: Other, Biological, Drug
Study Drugs: Bortezomib, Daratumumab and Hyaluronidase-fihj, Dexamethasone, Lenalidomide
Study Phase: Phase 3
Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)
Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)
Enrollment Status: Recruiting
Publish Date: November 13, 2025
Intervention Type: Other, Biological, Drug
Study Drugs: Daratumumab, Dexamethasone, Lenalidomide
Study Phase: Phase 3
A Randomized Phase III Study of the Addition of Venetoclax to Ibrutinib and Obinutuzumab Versus Ibrutinib and Obinutuzumab in Untreated Younger Patients With Chronic Lymphocytic Leukemia (CLL)
A Randomized Phase III Study of the Addition of Venetoclax to Ibrutinib and Obinutuzumab Versus Ibrutinib and Obinutuzumab in Untreated Younger Patients With Chronic Lymphocytic Leukemia (CLL)
Enrollment Status: Active_not_recruiting
Publish Date: November 17, 2025
Intervention Type: Other, Procedure, Drug, Biological
Study Drugs: Ibrutinib, Obinutuzumab, Venetoclax
Study Phase: Phase 3
A Randomized Phase III Study of Ibrutinib Plus Obinutuzumab Versus Ibrutinib Plus Venetoclax and Obinutuzumab in Untreated Older Patients (>/= 65 Years of Age) With Chronic Lymphocytic Leukemia (CLL)
A Randomized Phase III Study of Ibrutinib Plus Obinutuzumab Versus Ibrutinib Plus Venetoclax and Obinutuzumab in Untreated Older Patients (>/= 65 Years of Age) With Chronic Lymphocytic Leukemia (CLL)
Enrollment Status: Active_not_recruiting
Publish Date: November 17, 2025
Intervention Type: Drug, Biological, Other
Study Drugs: Ibrutinib, Obinutuzumab, Venetoclax
Study Phase: Phase 3
A Phase II/III Randomized Study of R-MiniCHOP With or Without CC-486 (Oral Azacitidine) in Participants Age 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma, Grade IIIB Follicular Lymphoma, Transformed Lymphoma, and High-Grade B-Cell Lymphomas With MYC AND BCL2 and/or BCL6 Rearrangements
A Phase II/III Randomized Study of R-MiniCHOP With or Without CC-486 (Oral Azacitidine) in Participants Age 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma, Grade IIIB Follicular Lymphoma, Transformed Lymphoma, and High-Grade B-Cell Lymphomas With MYC AND BCL2 and/or BCL6 Rearrangements
Enrollment Status: Suspended
Publish Date: October 06, 2025
Intervention Type: Drug, Biological, Procedure, Other
Study Drugs: Cyclophosphamide, Doxorubicin Hydrochloride, Oral Azacitidine, Prednisone, Rituximab, Vincristine Sulfate
Study Phase: Phase 2/Phase 3
View 3 Less Clinical Trials

1 Total Publications

Myelodysplastic syndromes spatial clusters in disease etiology and outcome.
Myelodysplastic syndromes spatial clusters in disease etiology and outcome.
Journal: Leukemia & lymphoma
Published: July 11, 2015
Similar Doctors
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Rahul Ravilla
Hematology Oncology | Hematology | Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Rahul Ravilla
Hematology Oncology | Hematology | Oncology

New York Oncology Hematology PC

43 New Scotland Ave, 
Albany, NY 
 (45.6 miles away)
518-262-6696
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Rahul Ravilla is a Hematologist Oncology specialist and a Hematologist in Albany, New York. Dr. Ravilla is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Upper Tract Urothelial Carcinoma (UTUC), WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, and Chromophobe Renal Cell Carcinoma.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Trevor J. Bayliss
Hematology Oncology | Hematology | Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Trevor J. Bayliss
Hematology Oncology | Hematology | Oncology

Berkshire Faculty Services Inc

165 Tor Ct, 
Pittsfield, MA 
 (61.4 miles away)
413-447-2701
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Trevor Bayliss is a Hematologist Oncology specialist and a Hematologist in Pittsfield, Massachusetts. Dr. Bayliss is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Paget Disease of the Breast, and Colorectal Cancer. Dr. Bayliss is currently accepting new patients.

Advanced in WT1-Related Wilms Tumor Syndromes
Dr. John P. Stoutenburg
Hematology Oncology | Hematology | Oncology
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. John P. Stoutenburg
Hematology Oncology | Hematology | Oncology

Glens Falls Hospital Inc

79 N St, Granville Medical Center, 
Granville, NY 
 (20.6 miles away)
518-642-0612
Languages Spoken:
English
See accepted insurances

John Stoutenburg is a Hematologist Oncology specialist and a Hematologist in Granville, New York. Dr. Stoutenburg is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Pleuropulmonary Blastoma, Posterior Fossa Tumor, and Bone Marrow Aspiration.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mason's expertise for a condition
ConditionClose
      • Advanced
      • Agranulocytosis
        Dr. Mason is
        Advanced
        . Learn about Agranulocytosis.
        See more Agranulocytosis experts
      • ALK-Positive Non-Small Cell Lung Cancer
        Dr. Mason is
        Advanced
        . Learn about ALK-Positive Non-Small Cell Lung Cancer.
        See more ALK-Positive Non-Small Cell Lung Cancer experts
      • Chronic B-Cell Leukemia (CBCL)
        Dr. Mason is
        Advanced
        . Learn about Chronic B-Cell Leukemia (CBCL).
        See more Chronic B-Cell Leukemia (CBCL) experts
      • Chronic Familial Neutropenia
        Dr. Mason is
        Advanced
        . Learn about Chronic Familial Neutropenia.
        See more Chronic Familial Neutropenia experts
      • Chronic Lymphocytic Leukemia (CLL)
        Dr. Mason is
        Advanced
        . Learn about Chronic Lymphocytic Leukemia (CLL).
        See more Chronic Lymphocytic Leukemia (CLL) experts
      • Classical Hodgkin Lymphoma
        Dr. Mason is
        Advanced
        . Learn about Classical Hodgkin Lymphoma.
        See more Classical Hodgkin Lymphoma experts
      View All 31 Advanced Conditions
      • Experienced
      • Acute Hepatic Porphyria (AHP)
        Dr. Mason is
        Experienced
        . Learn about Acute Hepatic Porphyria (AHP).
        See more Acute Hepatic Porphyria (AHP) experts
      • Acute Mountain Sickness
        Dr. Mason is
        Experienced
        . Learn about Acute Mountain Sickness.
        See more Acute Mountain Sickness experts
      • Adult Immune Thrombocytopenia
        Dr. Mason is
        Experienced
        . Learn about Adult Immune Thrombocytopenia.
        See more Adult Immune Thrombocytopenia experts
      • Adult Soft Tissue Sarcoma
        Dr. Mason is
        Experienced
        . Learn about Adult Soft Tissue Sarcoma.
        See more Adult Soft Tissue Sarcoma experts
      • Anaplastic Large Cell Lymphoma
        Dr. Mason is
        Experienced
        . Learn about Anaplastic Large Cell Lymphoma.
        See more Anaplastic Large Cell Lymphoma experts
      • Anemia
        Dr. Mason is
        Experienced
        . Learn about Anemia.
        See more Anemia experts
      View All 127 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2026 All Rights Reserved